Joined Today: 1

DUSA DUSA Pharmaceuticals,, Stock Message Board

All Messages

DUSA Message Board Home | Join The DUSA Group |

#15: DUSA Pharmaceuticals Announces $11 Million in Private Placement of Common Stock and Warrants to Institutional Investors
FastFun	November 27, 2007 09:22:52 PM
DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin... view message ignore post recommend post

#14: DUSA News DUSA Pharmaceuticals Signs Merger Agreement To Acquire Sirius Laboratories
NewsBot	January 3, 2006 12:50:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 3, 2006-- Strengthens DUSA's Position in the Dermatology Market DUSA Pharmaceuticals, Inc.(R) (NASDAQ NMS:DUSA), developer and marketer of... view message ignore post recommend post

#13: DUSA News DUSA Pharmaceuticals Reports Third Quarter Corporate Highlights and Financial Results
NewsBot	November 4, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 4, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) reported today its corporate highlights and financial results for the third quarter ended September... view message ignore post recommend post

#12: DUSA News DUSA Pharmaceuticals, Inc. to Host Third Quarter 2005 Corporate Highlights and Financial Results Conference Call
NewsBot	November 1, 2005 02:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 1, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that its third quarter corporate highlights and financial results press release will be... view message ignore post recommend post

#11: DUSA News DUSA Pharmaceuticals to Present at CIBC World Markets 16th Annual Healthcare Conference in New York
NewsBot	October 31, 2005 02:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 31, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that Dr. Geoff Shulman, Chairman and CEO and Mr. Bob Doman, President & COO, will be... view message ignore post recommend post

#10: DUSA News CORRECTING and REPLACING DUSA Pharmaceuticals, Inc.: Independent Investigator Reports Complete Clearing Of Recalcitrant Inflammatory Acne Using Levulan(R) Photodynamic Therapy With Long Pulse Dye Laser
NewsBot	October 28, 2005 10:52:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 28, 2005--Please replace the release with the following corrected version due to multiple revisions. DUSA PHARMACEUTICALS, INC.: INDEPENDENT INVESTIGATOR... view message ignore post recommend post

#9: DUSA News DUSA Pharmaceuticals to Present at The Rodman & Renshaw Techvest 7th Annual Healthcare Conference in New York
NewsBot	October 27, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 27, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that Dr. Geoff Shulman, Chairman and CEO and Mr. Bob Doman, President & COO, will be... view message ignore post recommend post

#8: DUSA News DUSA Pharmaceuticals, Inc.: Positive Independent Study Reports that Levulan'R' Photodynamic Therapy Using Intense Pulsed Light 'IPL' Significantly Improves Photodamaged Skin Compared to IPL Alone
NewsBot	October 20, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 20, 2005-- Groundbreaking Study in ARCHIVES OF DERMATOLOGY Offers Improved Treatments for Individuals Suffering From Premature Skin Damage DUSA... view message ignore post recommend post

#7: DUSA News DUSA Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference
NewsBot	September 21, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Sept. 21, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that Dr. Geoffrey Shulman, the Company's Chairman & CEO and Mr. Robert Doman, the... view message ignore post recommend post

#6: DUSA News DUSA Pharmaceuticals Reports Second Quarter Financial Results
NewsBot	August 3, 2005 12:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Aug. 3, 2005-- Company To Streamline Operations DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) a leading biopharmaceutical company developing... view message ignore post recommend post

#5: DUSA News DUSA Pharmaceuticals, Inc. To Host Second Quarter 2005 Corporate Highlights And Financial Results Conference Call
NewsBot	July 29, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--July 29, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that its second quarter corporate highlights and financial results press release will be... view message ignore post recommend post

#3: DUSA News Dusa Announces Second Quarter 2005 Levulan'R' Kerastick'R' And BLU-U'R' Sales
NewsBot	July 14, 2005 10:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--July 14, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) today announced second quarter (Q2) Levulan(R) Kerastick(R) and BLU-U(R) end-user sales. For Q2... view message ignore post recommend post

#4: DUSA News DUSA Announces Resignation of Officer
NewsBot	July 14, 2005 10:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--July 14, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) today announced that Gary Talarico, VP of Sales, had resigned for personal reasons on July 9, 2005.... view message ignore post recommend post

#2: DUSA News DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second Quarter 2005 Levulan'R' Kerastick'R' and BLU-U'R' Sales Update
NewsBot	July 12, 2005 01:00:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--July 12, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that an update regarding second quarter Levulan Kerastick and BLU-U end user sales will be... view message ignore post recommend post

#1: DUSA News DUSA Provides Investor Update
NewsBot	June 22, 2005 08:43:00 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--June 22, 2005--In response to current market conditions, DUSA Pharmaceuticals (NASDAQ NMS:DUSA) reports that it now expects sales of its Levulan(R) Kerastick(R)... view message ignore post recommend post

Group Home | Login if you want to post a message